THE RELEVANCE OF MEDICAL LABORATORY DIAGNOSIS IN CORONAVIRUS IN SUSPECTED HUMAN CASES by JOHNKENNEDY, NNODIM et al.
Vol 8, Issue 4, 2020 ISSN -  2321-4406 
THE RELEVANCE OF MEDICAL LABORATORY DIAGNOSIS IN CORONAVIRUS IN 
SUSPECTED HUMAN CASES
NNODIM JOHNKENNEDY1*, EDWARD UKAMAKA1, DUNGA KINGSLEY EXCEL2, NJOKUOBI TREASURE3,  
NJOKU CHUKWUDI JOSEPH4, UDUJIH HELEN IFEOMA1
1Department of Medical Laboratory Science, Faculty of Health Science, Imo State University, Owerri. 2Department of Medical Laboratory 
Science, Madonna University Elele Rivers State Nigeria. 3Department of Microbiology, Faculty of Science, Imo State University, Owerri. 
4Department of Pharmacology, Faculty of Basic Medical Sciences, Niger Delta University Amassoma, Bayelsa State Nigeria.  
Email: johnkennedy23@yahoo.com
Received: 06 April 2020, Revised and Accepted: 22 May 2020
ABSTRACT
Coronaviruses are a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle 
East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome. Coronavirus disease (Covid-19) is an infectious disease caused by a 
new virus. It leads to respiratory illness with symptoms such as a cough, fever, and in more severe cases, difficulty breathing. One can be protected by 
washing hands regularly, avoiding touching your face, and avoiding close contact with individuals who are unhealthy. It is transmitted through contact 
with an infected individual when they cough or sneeze. It could be transmitted when an individual touches a surface or object that has the virus on it, 
then touches the eyes, nose, or mouth. Some laboratory test to diagnose covid-19 includes real-time RT-PCR primer and probe and CDC serology test. 
It is very necessary that covid-19 is diagnosed for accurate treatment and management.
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INTRODUCTION
Coronavirus can be called covid-19. It is a pandemic infection which 
can cause immediate, mild upper lung infection. This covid-19 was 
discovered in December 2019 in Wuhan, China [1]. The rate of spread of 
this pandemic is unprecedented. The whole world is indeed challenged 
by this global infection. These viruses are mainly consist of various RNA 
virus in the Coronaviridae family. They are subclassed into four genera: 
Alpha, beta, gamma, and delta. They result in disease of placid to harsh 
cases in human and animal. Although the endemic human coronavirus 
such as alphacorona virus and betacorona viruses can lead to influenza-
like illness or pneumonia in humans, while viruses in the genera Gamma- 
and deltacoronavirus primarily infect birds but not exclusively [2].
Some clinical symptoms and manifestations
Covid-19 could attack the trachea through the organ of smell. This could 
happen between the incubation period of 7–10 days. It is pertinent to 
note that after this period, nasal obstruction, sneezing, runny nose, and 
occasionally dry cough can result [3]. This can lead to the shedding of 
the virus in the nasal secretions. On the other hand, this covid-19 may 
lead to disease of the lower airways [4].
These coronaviruses are highly picky and grow only in differentiated 
respiratory epithelial cells according to studies in both organ cultures 
and human volunteers. Consequently, infected cells yield vacuolation. 
It then shows damaged cilia and may produce syncytia [5]. This 
impairment of cells could lead to the production of inciting mediators. 
This leads to increased temperature of the mucosa as well as nasal 
secretion resulting in swelling and inflammation. Consequently, 
obstruction of air ways and sneezing  are stimulated [6].
At the initial stage, individuals infected with the virus may display no 
symptoms. However, some symptoms such as fever, dry cough, fatigue, 
and briefness of breath may be indicated later [7]. Other symptoms 
which may be dangerous include difficulty in respiration, constant 
chest ache or stress, uncertainty, inability to wake with ease, and bluish 
countenance. It important to note that runny nasal secretions, increased 
sneezes, or sore throat may be seen. In fact, symptoms such as nausea, 
vomiting, and diarrhea may be in different ranges [8].
It is important to note that the period between the moment when 
someone is attacked with the virus and the time when the symptoms 
begin to manifest [9]. This is the incubation time. The incubation time 
for coronavirus is 7–10 days, but may fall between 4 and 14 days [10].
Laboratory tests for covid-19
The medical laboratory diagnostic tests for coronavirus include molecular tests 
and serology tests. This means diagnostic testing for covid-19 is undertaken 
using two varied approaches which are Whole Genome Sequencing and 
Real-Time Reverse Transcriptase PCR (RT-PCR) [11]. Meanwhile, almost all 
diagnostic testing for covid-19 is done using RT-PCR [12].
The clinical and outbreak control should be guided by a medical 
laboratory scientist, where suspected cases must be vetted for the 
virus with nucleic acid amplification tests (NAATs), such as RT-PCR. The 
decision to test must come from clinical and epidemiological factors 
and associated with a calculation of the likelihood of infection [13]. PCR 
testing can be considered in the evaluation of persons who have had 
contact with a coronavirus case [14].
The medical laboratories carrying out the testing for the coronavirus should 
follow strict biosafety practices. NAAT detects the standard sequence of 
the virus RNA such as real-time reverse-transcription polymerase chain 
reaction (RT-PCR) with confirmation to nucleic acid sequencing when 
necessary [15]. The laboratory testing includes the following steps:
Determining confirmation
To consider a case as confirmed, the following needs to be ensured, 
where the virus is not prevalent. A positive NAAT results for at least 
two different targets on the genome, of which at least one target is 
likely more specific, or one positive NAAT result for the presence of beta 
coronavirus. Coronavirus is can be further identified by sequencing the 
genome of the virus [15,16].
Serological testing
Serological testing can aid the diagnosis of an ongoing outbreak and 
retrospective evaluation. In cases, where NAAT assays are negative, and 
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there is a strong epidemiological connection to coronavirus infection, 
paired serum samples can support the diagnosis that once validated tests 
are accessible. Serum specimen can be stored for these purposes [17].
Viral sequencing
In fact, providing confirmation of the presence of the virus, sequencing 
of a percentage of sample from clinical cases, is important to monitor 
for viral genome mutations [18].
Viral culture
Virus isolation may not be recommended as a diagnostic procedure [19].
Coronavirus diagnostic test kits
Various companies worldwide are manufacturing the coronavirus 
diagnostic test kits, including:
1. GenMark Diagnostics, Inc. – ePlex Research Use Only (RUO) test kits 
are provided by GenMark company.
2. BioFire Diagnostics – Film Array® Respiratory (RP and RP2) Panels. 
It is called BioFire Respiratory Panels. They are tests made to 
help clinicians quickly diagnose respiratory infections, which add 
up to a significant health care burden and present with nearly 
indistinguishable symptoms.
3. Cephied Inc. – This company is for the development of a test for 
the Coronavirus Strain (2019-nCoV). The test will be designed for 
use on any of its 23,000 GeneXpert Systems placed worldwide and 
is likely to deliver point-of-care results in about 30 min.
4. Meridian Biosciences creates a “Master Mix.” This works as the 
building blocks for rapid testing of the coronavirus. The kit tests 
RNA similar to how tests are done for influenza [20].
Sample Collection
The process of sample collection is as follows:
A. Safety during sample collection
 It is very necessary to ensure that safe collection mechanisms are in 
use. The workforce must be adequately trained for suitable sample 
collection, storage, packaging, and transport. Specimens collected for 
diagnosis must be considered as possibly infectious material [19].
B. The sample to be collected
 Mostly airways specimen must be collected, either upper respiratory 
or lower respiratory samples. Besides this, other medical sample may 
be collected as the virus had been reported in blood and feces [18].
C. Packaging and shipment of clinical sample
 In fact, the correct handling samples and its storage in 2–8°C are 
important. Transport of the samples within the country should 
adhere with applicable national regulations [10].
Prevention
One can be protected and prevented from spreading the virus to others 
through:
•	 Washing of hands frequently for 20 s, with the aid of soap and water 
as well cleaning the hands with sanitizers.
•	 Covering of nose and mouth with a non-reusable tissue or bend elbow 
during coughing as well as sneezing sneezing.
•	 Avoiding getting in touch physically with individuals who are 
unhealthy.
•	 Staying home when feel unhealthy and restrain from others.
•	 Avoiding touching the organ of sight, organ of smell, as well as mouth 
if the hands are dirty as well as adhering strictly to appropriate 
biosafety practices [21].
CONCLUSION
Coronaviruses have complex or specific nutritional requirements 
and grow only in specific airway epithelium cells. Infected cells result 
to essentially enclosed compartments which are filled with water 
containing inorganic and organic molecules, show damaged cilia and 
may form a multinucleate mass of cytoplasm that is not separated 
into cells. Cell impairment brings about the release of inflammatory 
attackers, which enhances nasal secretion and causes irritation and 
swelling. These responses lead to obstruction of the airways, increase 
the temperature of the mucosa and sneezing. Hence, there is a need to 
do laboratory test for proper guidance.
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